Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, is the company being led by leadership that is RELATIVELY NEW TO ITS ROLE — a chief executive, operating chief, or equivalent top operator who has taken charge within roughly the last year or so — AND does that leadership describe CONCRETE CHANGES IT HAS ALREADY MADE to how the company operates, sells, invests, or is organized, with at least some EARLY REAL RESULTS from those changes already visible in the current business?
Answer YES when the transcript conveys, in whatever form fits the business, ONE coherent situation: newly installed leadership (promoted from inside or brought from outside — either counts) is visibly running the company differently, and the difference has moved past intention into execution with something already to show. The changes may take whatever form fits the industry — a reshaped priority or portfolio, a changed go-to-market or operating approach, different people or structure, redirected investment, a fixed problem — and the early results may be modest, but must be real and current: actual orders, customers, performance, costs, or activity that management connects to the changes made. It should come through that the new leader speaks with ownership of the agenda — describing what they found, what they changed, and what is now happening — rather than merely continuing a predecessor's script.
Answer NO if there is no indication of leadership being new to the top role within roughly the past year or so. NO if the new leader describes only plans, reviews underway, or intentions with nothing yet changed. NO if changes are described but no early real results from them are pointed to anywhere on the call. NO if the leadership change is a caretaker, interim, or ceremonial arrangement. NO if the new-leader agenda appears only in an analyst's question that management does not itself substantiate. Use only the supplied transcript. Answer only YES or NO.
| Ticker | Company | Call | Date | Call grade |
| NOAH |
Noah Holdings Limited |
Q1 2024 |
2024-05-30 |
D |
| FTRE |
Fortrea Holdings Inc. |
Q1 2024 |
2024-05-13 |
D |
| BODI |
The Beachbody Company, Inc. |
Q1 2024 |
2024-05-06 |
D |
| EBS |
Emergent BioSolutions Inc. |
Q1 2024 |
2024-05-01 |
C |
| KOPN |
Kopin Corporation |
Q4 2023 |
2024-03-14 |
C+ |
| PBR |
Petróleo Brasileiro S.A. - Petrobras |
Q4 2023 |
2024-03-08 |
D |
| CMBM |
Cambium Networks Corporation |
Q4 2023 |
2024-02-15 |
D |
| AXTA |
Axalta Coating Systems Ltd. |
Q4 2023 |
2024-02-08 |
B+ |
| SANG |
Sangoma Technologies Corporation |
Q2 2024 |
2024-02-08 |
D |
| CHRW |
C.H. Robinson Worldwide, Inc. |
Q4 2023 |
2024-01-31 |
C+ |
| NVAX |
Novavax, Inc. |
Q3 2023 |
2023-11-09 |
F |
| KC |
Kingsoft Cloud Holdings Limited |
Q2 2023 |
2023-08-22 |
C |
| ATIP |
ATI Physical Therapy, Inc. |
Q2 2023 |
2023-08-07 |
C+ |
| LIDR |
AEye, Inc. |
Q2 2023 |
2023-08-07 |
F |
| TRIP |
Tripadvisor, Inc. |
Q1 2023 |
2023-05-04 |
D |
| BHC |
Bausch Health Companies Inc. |
Q4 2022 |
2023-02-23 |
F |
| DLR |
Digital Realty Trust, Inc. |
Q4 2022 |
2023-02-16 |
C+ |
| CIM |
Chimera Investment Corporation |
Q4 2022 |
2023-02-15 |
D |
| PHG |
Koninklijke Philips N.V. |
Q4 2022 |
2023-01-30 |
D |
| MEC |
Mayville Engineering Company, Inc. |
Q3 2022 |
2022-11-05 |
B+ |
| APOG |
Apogee Enterprises, Inc. |
Q2 2023 |
2022-09-20 |
A |
| CURV |
Torrid Holdings Inc. |
Q2 2022 |
2022-09-07 |
D |
| SYM |
Symbotic Inc. |
Q3 2022 |
2022-08-01 |
B+ |
| GORO |
Gold Resource Corporation |
Q4 2021 |
2022-03-11 |
B |
| KD |
Kyndryl Holdings, Inc. |
Q4 2021 |
2022-03-01 |
C+ |
| NUS |
Nu Skin Enterprises, Inc. |
Q3 2021 |
2021-11-03 |
F |
| UBS |
UBS Group AG |
Q3 2021 |
2021-10-26 |
C+ |
| LPTH |
LightPath Technologies, Inc. |
Q4 2021 |
2021-09-09 |
D |
| JRVR |
James River Group Holdings, Ltd. |
Q2 2021 |
2021-08-07 |
B |
| UFI |
Unifi, Inc. |
Q4 2021 |
2021-08-07 |
B |
| INTC |
Intel Corporation |
Q2 2021 |
2021-07-22 |
D |
| TCBI |
Texas Capital Bancshares, Inc. |
Q2 2021 |
2021-07-21 |
F |
| MVIS |
MicroVision, Inc. |
Q2 2018 |
2018-07-31 |
D |
| GSK |
GSK plc |
Q2 2018 |
2018-07-25 |
B |
| FLS |
Flowserve Corporation |
Q4 2017 |
2018-02-16 |
D |
| VFC |
V.F. Corporation |
Q4 2017 |
2018-02-16 |
A |
| TDC |
Teradata Corporation |
Q3 2017 |
2017-11-02 |
C+ |
| UAA |
Under Armour, Inc. |
Q3 2017 |
2017-10-31 |
F |
| STKL |
SunOpta Inc. |
Q2 2017 |
2017-08-09 |
C+ |
| FRPT |
Freshpet, Inc. |
Q2 2017 |
2017-08-07 |
B+ |
| BIIB |
Biogen Inc. |
Q2 2017 |
2017-07-25 |
B |
| RCI |
Rogers Communications Inc. |
Q2 2017 |
2017-07-20 |
C |
| MRVL |
Marvell Technology, Inc. |
Q1 2018 |
2017-05-25 |
B+ |
| MRIN |
Marin Software Incorporated |
Q4 2016 |
2017-02-28 |
D |
| CRD.B |
Crawford & Company's |
Q3 2016 |
2016-11-07 |
B+ |
| TGI |
Triumph Group, Inc. |
Q2 2017 |
2016-11-03 |
C+ |
| GES |
Guess?, Inc. |
Q1 2017 |
2016-05-25 |
F |
| DD |
DuPont de Nemours, Inc. |
Q1 2016 |
2016-04-26 |
B+ |
| UIS |
Unisys Corporation |
Q4 2015 |
2016-01-29 |
B |
| SAN |
Banco Santander, S.A. |
Q4 2015 |
2016-01-27 |
B |
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.